Unexplained Early Neurological Deterioration After Intravenous Thrombolysis Incidence, Predictors, and Associated Factors

被引:115
|
作者
Seners, Pierre [1 ,2 ]
Turc, Guillaume [1 ,2 ]
Tisserand, Marie [1 ,3 ]
Legrand, Laurence [1 ,3 ]
Labeyrie, Marc-Antoine [1 ,3 ]
Calvet, David [1 ,2 ]
Meder, Jean-Francois [1 ,3 ]
Mas, Jean-Louis [1 ,2 ]
Oppenheim, Catherine [1 ,3 ]
Baron, Jean-Claude [1 ,2 ]
机构
[1] Univ Paris 05, Sorbonne Paris Cite, INSERM, UMR S894, Paris, France
[2] Ctr Hosp St Anne, Serv Neurol, Paris, France
[3] Ctr Hosp St Anne, Serv Neuroradiol, Paris, France
关键词
stroke; thrombolytic therapy; ACUTE ISCHEMIC-STROKE; CLINICAL DETERIORATION; ATRIAL-FIBRILLATION; HYPERGLYCEMIA; IMPROVEMENT; MANAGEMENT; INFARCTION; TISSUE; TRIAL; PA;
D O I
10.1161/STROKEAHA.114.005426
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-Early neurological deterioration (END) after anterior circulation stroke is a serious clinical event strongly associated with poor outcome. Regarding specifically END occurring within 24 hours of intravenous recombinant tissue-type plasminogen activator, apart from definite causes such as symptomatic intracranial hemorrhage and malignant edema whose incidence, predictors, and clinical management are well established, little is known about END without clear mechanism (ENDunexplained). Methods-We analyzed 309 consecutive patients thrombolysed intravenously <= 4.5 hours from onset of anterior circulation stroke. ENDunexplained was defined as a >= 4-point deterioration on 24-hour National Institutes of Health Stroke Scale, without definite mechanism on concomitant imaging. ENDunexplained and no-END patients were compared for pretreatment clinical and imaging (including magnetic resonance diffusion and diffusion/perfusion mismatch volumes) data and 24-hour post-treatment clinical (including blood pressure and glycemic changes) and imaging (24-hour recanalization) data, using univariate logistic regression. Exploratory multivariate analysis was also performed after variable reduction, with bootstrap analysis for internal validation. Results-Among 33 END patients, 23 (7% of whole sample) had ENDunexplained. ENDunexplained was associated with poor 3-month outcome (P<0.01). In univariate analysis, admission predictors of ENDunexplained included no prior use of antiplatelets (P=0.02), lower National Institutes of Health Stroke Scale score (P<0.01), higher glycemia (P=0.03), larger mismatch volume (P=0.03), and proximal occlusion (P=0.01), with consistent results from the multivariate analysis. Among factors recorded during the first 24 hours, only no recanalization was associated with END unexplained in multivariate analysis (P=0.02). Conclusions-ENDunexplained affected 7% of patients and accounted for most cases of END. Several predictors and associated factors were identified, with important implications regarding underlying mechanisms and potential prevention of this ominous event.
引用
收藏
页码:2004 / 2009
页数:6
相关论文
共 50 条
  • [1] Is Unexplained Early Neurological Deterioration After Intravenous Thrombolysis Associated With Thrombus Extension?
    Seners, Pierre
    Hurford, Robert
    Tisserand, Marie
    Turc, Guillaume
    Legrand, Laurence
    Naggara, Olivier
    Mas, Jean-Louis
    Oppenheim, Catherine
    Baron, Jean-Claude
    STROKE, 2017, 48 (02) : 348 - 352
  • [2] Corticospinal Tract Hypoperfusion Associated With Unexplained Early Neurological Deterioration After Intravenous Thrombolysis
    Zhang, Danfeng
    Zhong, Wansi
    Chen, Luowei
    Xu, Chao
    Yan, Shenqiang
    Zhou, Ying
    Ma, Xiaodong
    Lou, Min
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [3] Mechanisms of Unexplained Neurological Deterioration After Intravenous Thrombolysis
    Tisserand, Marie
    Seners, Pierre
    Turc, Guillaume
    Legrand, Laurence
    Labeyrie, Marc-Antoine
    Charron, Sylvain
    Meder, Jean-Francois
    Mas, Jean-Louis
    Oppenheim, Catherine
    Baron, Jean-Claude
    STROKE, 2014, 45 (12) : 3527 - +
  • [4] The Incidence and Associated Factors of Early Neurological Deterioration After Thrombolysis Results From SITS Registry
    Yu, Wai M.
    Abdul-Rahim, Azmil H.
    Cameron, Alan C.
    Korv, Janika
    Sevcik, Petr
    Toni, Danilo
    Lees, Kennedy R.
    STROKE, 2020, 51 (09) : 2705 - 2714
  • [5] Early neurological deterioration after thrombolysis: Clinical and imaging predictors
    Simonsen, Claus Z.
    Schmitz, Marie L.
    Madsen, Mette H.
    Mikkelsen, Irene K.
    Chandra, Ronil V.
    Leslie-Mazwi, Thabele
    Andersen, Grethe
    INTERNATIONAL JOURNAL OF STROKE, 2016, 11 (07) : 776 - 782
  • [6] Hypoperfusion in lenticulostriate arteries territory related to unexplained early neurological deterioration after intravenous thrombolysis
    Zhou, Ying
    Zhong, Wansi
    Wang, Anli
    Huang, Wanyun
    Yan, Shenqiang
    Zhang, Ruiting
    Liu, Chang
    Fu, Jingjing
    Jiaerken, Yeerfan
    Lou, Min
    INTERNATIONAL JOURNAL OF STROKE, 2019, 14 (03) : 306 - 309
  • [7] A risk prediction model for unexplained early neurological deterioration following intravenous thrombolysis
    Zhu, Bifeng
    Wang, Dan
    Zuo, Jing
    Huang, Yi
    Gao, Chang
    Jiang, Haiwei
    Yan, Dan
    EGYPTIAN JOURNAL OF NEUROLOGY PSYCHIATRY AND NEUROSURGERY, 2024, 60 (01):
  • [8] Predictors of Early Neurological Deterioration Following Intravenous Thrombolysis: Difference between Risk Factors for Ischemic and Hemorrhagic Worsening
    Nair, Srikumar B.
    Somarajan, Deepthi
    Pillai, Rammohan K.
    Balachandran, Keerthi
    Sathian, Sona
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2022, 25 (04) : 627 - 633
  • [9] Factors affecting early neurological deterioration after intravenous alteplase treatment for branch atheromatous disease
    Mizuno, Satoko
    Deguchi, Ichiro
    Takahashi, Shinichi
    Arai, Noriko
    Nakagami, Toru
    Kimura, Ryutaro
    Oryu, Kiichiro
    Watanabe, Kaito
    Ueda, Sae
    Fujiwara, Shinako
    Kato, Yuji
    Hayashi, Takeshi
    Suda, Satoshi
    NEUROLOGY AND CLINICAL NEUROSCIENCE, 2025, 13 (01): : 57 - 62
  • [10] Leukoaraiosis and Early Neurological Recovery after Intravenous Thrombolysis
    McAlpine, Heidi
    Churilov, Leonid
    Mitchell, Peter
    Dowling, Richard
    Teo, Sarah
    Yan, Bernard
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2014, 23 (09) : 2431 - 2436